OSCAR is a collagen receptor that costimulates osteoclastogenesis in DAP12-deficient humans and mice

Journal of Clinical Investigation

Volumn 121, Issue 9, 2011, Pages 3505-3516

  Barrow, Alexander David ^a,b   Raynal, Nicolas ^a   Andersen, Thomas Levin ^c   Slatter, David A ^a   Bihan, Dominique ^a   Pugh, Nicholas ^a   Cella, Marina ^b   Kim, Taesoo ^d   Rho, Jaerang ^e   Negishi Koga, Takako ^f   Delaisse, Jean Marie ^c   Takayanagi, Hiroshi ^f   Lorenzo, Joseph ^g   Colonna, Marco ^b   Farndale, Richard W ^a   Choi, Yongwon ^d   Trowsdale, John ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e Chungnam National University   (South Korea)

^f TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^g UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; COLLAGEN; COLLAGEN RECEPTOR; DNAX ACTIVATING PROTEIN OF 12 KDA; FC RECEPTOR; OSTEOCLAST ASSOCIATED RECEPTOR; OSTEOCLAST DIFFERENTIATION FACTOR; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE DYSPLASIA; CELL MATURATION; EXTRACELLULAR MATRIX; GENETIC DISORDER; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MEMBRANOUS LIPODYSTROPHY; NONHUMAN; OSTEOCLASTOGENESIS; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AMINO ACID SEQUENCE; ANIMALS; CELLS, CULTURED; COLLAGEN; HUMANS; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; MONOCYTES; OSTEOCLASTS; PROTEIN BINDING; RANK LIGAND; RECEPTORS, CELL SURFACE; RECEPTORS, IMMUNOLOGIC; RECOMBINANT FUSION PROTEINS; SEQUENCE ALIGNMENT; TRANSFORMING GROWTH FACTOR BETA1;

EID: 80052388933     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI45913     Document Type: Article

References (60)

1. Geissmann F., Manz M.G., Jung S., Sieweke M.H., Merad M., Ley K. Development of monocytes, macrophages, and dendritic cells. Science. 2010; 327(5966):656-661.
2. Gordon S., Martinez F.O. Alternative activation of macrophages: Mechanism and functions. Immunity. 2010;32(5):593-604.
3. Martin T.J. Paracrine regulation of osteoclast formation and activity: Milestones in discovery. J Musculoskelet Neuronal Interact. 2004;4(3):243-253. (Pubitemid 39504352)
4. Kong Y.Y., et al. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature. 1999; 402(6759):304-309.
5. Paloneva J., et al. Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts. Nat Genet. 2000;25(3):357-361. (Pubitemid 30437329)
6. Teitelbaum S.L. Bone resorption by osteoclasts. Science. 2000;289(5484):1504-1508.
7. Kong Y.Y., et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature. 1999; 397(6717):315-323.
8. Lacey D.L., et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell. 1998;93(2):165-176. (Pubitemid 28180851)
9. Koga T., et al. Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis. Nature. 2004;428(6984):758-763. (Pubitemid 38508286)
10. Mocsai A., et al. The immunomodulatory adapter proteins DAP12 and Fc receptor gamma-chain (FcRgamma) regulate development of functional osteoclasts through the Syk tyrosine kinase. Proc Natl Acad Sci U S A. 2004;101(16):6158- 6163. (Pubitemid 38520544)
11. Negishi-Koga T., Takayanagi H. Ca2+-NFATc1 signaling is an essential axis of osteoclast differentiation. Immunol Rev. 2009;231(1):241-256.
12. Ivashkiv L.B. Cross-regulation of signaling by ITAM-associated receptors. Nat Immunol. 2009; 10(4):340-347.
13. Shinohara M., et al. Tyrosine kinases Btk and Tec regulate osteoclast differentiation by linking RANK and ITAM signals. Cell. 2008;132(5):794-806. (Pubitemid 351312796)
14. Cella M., Buonsanti C., Strader C., Kondo T., Salmaggi A., Colonna M. Impaired differentiation of osteoclasts in TREM-2-deficient individuals. J Exp Med. 2003;198(4):645-651. (Pubitemid 37040398)
15. Klunemann H.H., et al. The genetic causes of basal ganglia calcification, dementia, and bone cysts: DAP12 and TREM2. Neurology. 2005;64(9):1502-1507. (Pubitemid 40617683)
16. Paloneva J., et al. DAP12/TREM2 deficiency results in impaired osteoclast differentiation and osteoporotic features. J Exp Med. 2003;198(4):669-675. (Pubitemid 37045349)
17. Merck E., et al. OSCAR is an FcRgamma-associated receptor that is expressed by myeloid cells and is involved in antigen presentation and activation of human dendritic cells. Blood. 2004; 104(5):1386-1395. (Pubitemid 39166516)
18. Kim N., Takami M., Rho J., Josien R., Choi Y. A novel member of the leukocyte receptor complex regulates osteoclast differentiation. J Exp Med. 2002; 195(2):201-209. (Pubitemid 34461264)
19. Collin-Osdoby P., Rothe L., Anderson F., Nelson M., Maloney W., Osdoby P. Receptor activator of NF-kappa B and osteoprotegerin expression by human microvascular endothelial cells, regulation by inflammatory cytokines, and role in human osteoclastogenesis. J Biol Chem. 2001;276(23):20659-20672.
20. Chow J., Chambers T.J. An assessment of the prevalence of organic material on bone surfaces. Calcif Tissue Int. 1992;50(2):118-122.
21. Miller S.C., Bowman B.M., Smith J.M., Jee W.S. Characterization of endosteal bone-lining cells from fatty marrow bone sites in adult beagles. Anat Rec. 1980;198(2):163-173. (Pubitemid 11160581)
22. Vanderwiel C. An ultrastructural study of the components which make up the resting surface of bone. Metab Bone Dis Rel Res. 1980;2(suppl):109-116.
23. Andersen T.L., et al. A physical mechanism for coupling bone resorption and formation in adult human bone. Am J Pathol. 2009;174(1):239-247.
24. Hauge E.M., Qvesel D., Eriksen E.F., Mosekilde L., Melsen F. Cancellous bone remodeling occurs in specialized compartments lined by cells expressing osteoblastic markers. J Bone Miner Res. 2001;16(9):1575-1582. (Pubitemid 32786425)
25. Miller S.C., Jee W.S. The bone lining cell: A distinct phenotype? Calcif Tissue Int. 1987;41(1):1-5.
26. Gelse K., Poschl E., Aigner T. Collagens-structure, function, and biosynthesis. Adv Drug Deliv Rev. 2003;55(12):1531-1546.
27. Eriksen E.F., Eghbali-Fatourechi G.Z., Khosla S. Remodeling and vascular spaces in bone. J Bone Miner Res. 2007;22(1):1-6. (Pubitemid 46032591)
28. Farndale R.W., Sixma J.J., Barnes M.J., De Groot P.G. The role of collagen in thrombosis and hemostasis. J Thromb Haemost. 2004;2(4):561-573. (Pubitemid 40185679)
29. Raynal N., et al. Use of synthetic peptides to locate novel integrin alpha2beta1-binding motifs in human collagen III. J Biol Chem. 2006;281(7):3821-3831. (Pubitemid 43847806)
30. Konitsiotis A.D., Raynal N., Bihan D., Hohenester E., Farndale R.W., Leitinger B. Characterization of high affinity binding motifs for the discoidin domain receptor DDR2 in collagen. J Biol Chem. 2008; 283(11):6861-6868.
31. Arase H., Mocarski E.S., Campbell A.E., Hill A.B., Lanier L.L. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science. 2002;296(5571):1323-1326. (Pubitemid 34522789)
32. Paloneva J., et al. Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype. Am J Hum Genet. 2002;71(3):656-662. (Pubitemid 34970138)
33. Helming L., et al. Essential role of DAP12 signaling in macrophage programming into a fusion-competent state. Sci Signal. 2008;1(43):ra11.
34. Otero K., et al. Macrophage colony-stimulating factor induces the proliferation and survival of macrophages via a pathway involving DAP12 and beta-catenin. Nat Immunol. 2009;10(7):734-743.
35. Peng Q., Malhotra S., Torchia J.A., Kerr W.G., Coggeshall K.M., Humphrey M.B. TREM2- and DAP12- dependent activation of PI3K requires DAP10 and is inhibited by SHIP1. Sci Signal. 2010;3(122):ra38.
36. Zou W., Reeve J.L., Liu Y., Teitelbaum S.L., Ross F.P. DAP12 couples c-Fms activation to the osteoclast cytoskeleton by recruitment of Syk. Mol Cell. 2008;31(3):422-431.
37. Kindle L., Rothe L., Kriss M., Osdoby P., Collin- Osdoby P. Human microvascular endothelial cell activation by IL-1 and TNF-alpha stimulates the adhesion and transendothelial migration of circulating human CD14+ monocytes that develop with RANKL into functional osteoclasts. J Bone Miner Res. 2006;21(2):193-206. (Pubitemid 43265285)
38. Thesingh C.W., Burger E.H. The role of mesenchyme in embryonic long bones as early deposition site for osteoclast progenitor cells. Dev Biol. 1983; 95(2):429-438. (Pubitemid 13163952)
39. Masuyama R., et al. Vitamin D receptor in chondrocytes promotes osteoclastogenesis and regulates FGF23 production in osteoblasts. J Clin Invest. 2006;116(12):3150-3159. (Pubitemid 44878629)
40. Herman S., et al. Induction of osteoclast-associated receptor, a key osteoclast costimulation molecule, in rheumatoid arthritis. Arthritis Rheum. 2008; 58(10):3041-3050.
41. Zhu X.W., Price N.M., Gilman R.H., Recarvarren S., Friedland J.S. Multinucleate giant cells release functionally unopposed matrix metalloproteinase-9 in vitro and in vivo. J Infect Dis. 2007;196(7):1076-1079. (Pubitemid 47580303)
42. Levental K.R., et al. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell. 2009;139(5):891-906.
43. Ma G., et al. Paired immunoglobin-like receptor- B regulates the suppressive function and fate of myeloid-derived suppressor cells. Immunity. 2011; 34(3):385-395.
44. Barrow A.D., Trowsdale J. You say ITAM and I say ITIM, let's call the whole thing off: The ambiguity of immunoreceptor signalling. Eur J Immunol. 2006; 36(7):1646-1653. (Pubitemid 44089030)
45. Mori Y., et al. Inhibitory immunoglobulin-like receptors LILRB and PIR-B negatively regulate osteoclast development. J Immunol. 2008;181(7):4742-4751.
46. Van Beek E.M., et al. Inhibitory regulation of osteoclast bone resorption by signal regulatory protein alpha. FASEB J. 2009;23(12):4081-4090.
47. Wu Y., Tworkoski K., Michaud M., Madri J.A. Bone marrow monocyte PECAM-1 deficiency elicits increased osteoclastogenesis resulting in trabecular bone loss. J Immunol. 2009;182(5):2672-2679.
48. Barrow A.D., Trowsdale J. The extended human leukocyte receptor complex: Diverse ways of modulating immune responses. Immunol Rev. 2008;224:98-123.
49. Lebbink R.J., et al. Collagens are functional, high affinity ligands for the inhibitory immune receptor LAIR-1. J Exp Med. 2006;203(6):1419-1425. (Pubitemid 43877604)
50. Kim G.S., et al. Association of the OSCAR promoter polymorphism with BMD in postmenopausal women. J Bone Miner Res. 2005;20(8):1342-1348. (Pubitemid 41033518)
51. Bouchon A., Facchetti F., Weigand M.A., Colonna M. TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature. 2001; 410(6832):1103-1107. (Pubitemid 32391042)
52. Barrow A.D., et al. Cutting edge: TREM-like transcript-1, a platelet immunoreceptor tyrosine- based inhibition motif encoding costimulatory immunoreceptor that enhances, rather than inhibits, calcium signaling via SHP-2. J Immunol. 2004;172(10):5838-5842. (Pubitemid 38621181)
53. Kennedy J., et al. A molecular analysis of NKT cells: Identification of a class-I restricted T cellassociated molecule (CRTAM). J Leukoc Biol. 2000; 67(5):725-734.
54. Angata T., Tabuchi Y., Nakamura K., Nakamura M. Siglec-15: An immune system Siglec conserved throughout vertebrate evolution. Glycobiology. 2007;17(8):838-846. (Pubitemid 47241821)
55. Takeshita S., Kaji K., Kudo A. Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts. J Bone Miner Res. 2000;15(8):1477-1488. (Pubitemid 30484517)
56. Kondo T., et al. Heterogeneity of presenile dementia with bone cysts (Nasu-Hakola disease): Three genetic forms. Neurology. 2002;59(7):1105-1107.
57. Mao D., Epple H., Uthgenannt B., Novack D.V., Faccio R. PLCgamma2 regulates osteoclastogenesis via its interaction with ITAM proteins and GAB2. J Clin Invest. 2006;116(11):2869-2879. (Pubitemid 44684472)
58. Lee S.H., et al. v-ATPase V0 subunit d2-deficient mice exhibit impaired osteoclast fusion and increased bone formation. Nat Med. 2010;12(12):1403-1409.
59. Rho J., Gong S., Kim N., Choi Y. TDAG51 is not essential for Fas/CD95 regulation and apoptosis in vivo. Mol Cell Biol. 2001;21(24):8365-8370. (Pubitemid 33108597)
60. Turnbull I.R., McDunn J.E., Takai T., Townsend R.R., Cobb J.P., Colonna M. DAP12 (KARAP) amplifies inflammation and increases mortality from endotoxemia and septic peritonitis. J Exp Med. 2005;202(3):363-369. (Pubitemid 41126953)